Taken together, our data demonstrated that TGF-β1-509C/T and codon 10 polymorphisms could be feasible to screen for individuals at risk for CLDs, especially for cirrhosis, CHB, and CHC. Here, TGFB1 is linked to cryohydrocytosis.